Cargando…
存在驱动基因突变肺鳞癌患者的临床病理特征及预后分析
BACKGROUND AND OBJECTIVE: It has been proven that epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and KRAS are common driver genes in non-small cell lung cancer (NSCLC). Molecular targeted therapy increases the overall response rate and progression-free survival (PFS) of p...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973419/ https://www.ncbi.nlm.nih.gov/pubmed/27760592 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.02 |